Cliff Asness AQR Capital Management
Cliff Asness is a co-founder of AQR Capital Management, a leading quantitative investment firm spanning equities, alternatives, and factor strategies. He is known for academic-informed research on value, momentum, and other systematic premia, as well as candid market commentary. Asness’s work bridges academic finance and large-scale institutional portfolio management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$354M |
| 2 |
Verizon
VZ
|
+$307M |
| 3 |
HCA Healthcare
HCA
|
+$256M |
| 4 |
Marathon Petroleum
MPC
|
+$239M |
| 5 |
Comcast
CMCSA
|
+$231M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$361M |
| 2 |
Texas Instruments
TXN
|
+$333M |
| 3 |
LyondellBasell Industries
LYB
|
+$305M |
| 4 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$298M |
| 5 |
Northrop Grumman
NOC
|
+$282M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.44% |
| 2 | Technology | 18.54% |
| 3 | Consumer Discretionary | 14.07% |
| 4 | Industrials | 10.25% |
| 5 | Financials | 9.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Nu Skin
NUS
$231M
| $84M | 0.1% |
1,370,284
-85,740
| -6% | -$5.78M |
|
227
BCE
BCE
$22.1B
| $83M | 0.1% |
2,101,853
+270,658
| +15% | +$11.1M |
|
228
Banco Santander Chile
BSAC
$16.6B
| $82.5M | 0.1% |
2,759,196
-211,766
| -7% | -$6.45M |
|
229
Wells Fargo
WFC
$254B
| $82.4M | 0.1% |
1,787,472
-59,324
| -3% | -$3.04M |
|
230
Prudential Financial
PRU
$41.8B
| $82.1M | 0.1% |
1,006,622
+633,443
| +170% | +$58.3M |
|
231
Cummins
CMI
$80.9B
| $82M | 0.1% |
613,463
-93,898
| -13% | -$13.3M |
|
232
Williams-Sonoma
WSM
$28B
| $81.2M | 0.09% |
3,220,890
-1,234,096
| -28% | -$35.3M |
|
233
Qiagen
QGEN
$9.1B
| $81.1M | 0.09% |
2,222,083
+13,850
| +0.6% | +$514K |
|
234
Las Vegas Sands
LVS
$30.5B
| $80.5M | 0.09% |
1,546,420
-340,997
| -18% | -$18.5M |
|
235
Cirrus Logic
CRUS
$5.78B
| $80.2M | 0.09% |
2,418,281
-347,745
| -13% | -$12.9M |
|
236
Crown Castle
CCI
$32.1B
| $80.2M | 0.09% |
738,176
-9,994
| -1% | -$1.1M |
|
237
Lincoln National
LNC
$8.07B
| $79.9M | 0.09% |
1,557,662
+556,379
| +56% | +$33.8M |
|
|
FITB
238
Fifth Third Bancorp
FITB
$49.7B
| $79.5M | 0.09% |
3,377,804
+725,252
| +27% | +$19.1M |
|
239
Western Digital
WDC
$166B
| $79.4M | 0.09% |
2,840,335
-2,393,698
| -46% | -$84.8M |
|
240
Clorox
CLX
$12.9B
| $78.8M | 0.09% |
511,120
-89,346
| -15% | -$13.9M |
|
241
Expeditors International
EXPD
$24.4B
| $78.4M | 0.09% |
1,151,528
-197,758
| -15% | -$13.9M |
|
242
Snap-on
SNA
$20.3B
| $77.5M | 0.09% |
533,589
-129,489
| -20% | -$20.5M |
|
243
Steel Dynamics
STLD
$32.8B
| $77.5M | 0.09% |
2,579,403
+621,180
| +32% | +$23.5M |
|
244
NVR
NVR
$16.9B
| $77.4M | 0.09% |
31,771
-26,673
| -46% | -$63.1M |
|
|
WBA
245
DELISTED
Walgreens Boots Alliance
WBA
| $76.9M | 0.09% |
1,125,247
+1,095,702
| +3,709% | +$85M |
|
246
Hanover Insurance
THG
$7.77B
| $76M | 0.09% |
650,613
-13,862
| -2% | -$1.56M |
|
|
TGNA
247
DELISTED
TEGNA Inc
TGNA
| $75.5M | 0.09% |
6,942,025
+2,459,013
| +55% | +$29.7M |
|
248
Universal Health Services
UHS
$10.4B
| $75.4M | 0.09% |
646,708
+394,974
| +157% | +$49.6M |
|
249
Boston Beer
SAM
$1.91B
| $75.4M | 0.09% |
312,879
+8,998
| +3% | +$2.52M |
|
|
DNB
250
DELISTED
Dun & Bradstreet
DNB
| $74.4M | 0.09% |
521,088
+157,989
| +44% | +$22.5M |
|
Similar funds
Cliff Asness's Q4 2018 Portfolio in Review
As of Q4 2018, Cliff Asness held 2,392 positions worth $86.3B, down 17% from $105B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Cliff Asness's Q4 2018 filing shows 138 new, 818 increased, 1,174 reduced and 217 closed positions. Its largest new stake was Linde: 705,153 shares worth $111M. The largest sale was Intel, an estimated $361M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 17% a quarter earlier, followed by Technology and Consumer Discretionary.
- Cliff Asness's largest Q4 2018 buy was Linde: 705,153 shares worth $111M.
- Cliff Asness added most to Merck in Q4 2018, an estimated $354M increase.
- Cliff Asness's biggest Q4 2018 reduction was Intel, cutting an estimated $361M.
- Cliff Asness fully exited Aetna Inc in Q4 2018, selling an estimated $104M.
- Cliff Asness's ten largest holdings make up 13% of its $86.3B portfolio in Q4 2018.
- Cliff Asness opened 138 new positions and closed 217 in Q4 2018.
- Cliff Asness's portfolio value fell 17% quarter-over-quarter to $86.3B.
Based on AQR Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.